Article Information
History
- November 5, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Zoe L. Lyski1,#,
- Myung S. Kim2,#,
- David Xthona Lee1,
- Hans-Peter Raué3,
- Vikram Raghunathan2,
- Janet Griffin2,
- Debbie Ryan2,
- Amanda E. Brunton4,
- Marcel E. Curlin5,
- Mark K. Slifka3,
- William B. Messer1,4,5 and
- Stephen E. Spurgeon2,*
- 1Department of Molecular Microbiology & Immunology, Oregon Health & Science University (OHSU), Portland, OR 97239, USA
- 2Knight Cancer Institute, Oregon Health & Science University (OHSU), Portland, OR 97239, USA
- 3Division of Neuroscience, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA
- 4OHSU-PSU School of Public Health, Portland, OR 97239, USA
- 5Department of Medicine, Division of Infectious Diseases, Oregon Health & Science University (OHSU), Portland, OR 97239, USA
- ↵*Corresponding author Phone: (503) 494-5058. Email: spurgeos{at}ohsu.edu
↵# contributed equally
Posted November 05, 2021.
Cellular and humoral Immune response to mRNA COVID-19 vaccination in subjects with chronic lymphocytic leukemia
